Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


7 Am J Dermatopathol
2 BMC Cancer
45 Br J Dermatol
2 Cancer Lett
1 Cancer Res
14 Clin Exp Dermatol
5 Int J Cancer
4 Int J Dermatol
9 J Cutan Pathol
6 J Dermatol
10 J Invest Dermatol
9 Plast Reconstr Surg
1 PLoS Genet
8 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Dermatopathol

  1. HATFIELD J, Saad S, Hendrick SJ
    An Infant With a Congenital Violaceous Plaque: Challenge.
    Am J Dermatopathol. 2023;45:e5-e6.

  2. HATFIELD J, Saad S, Hendrick SJ
    An Infant With a Congenital Violaceous Plaque: Answer.
    Am J Dermatopathol. 2023;45:151-152.

  3. MAYO-MARTINEZ F, Moro R, Traves V, Llombart B, et al
    Trichoepithelioma on the Finger: A Rare Location and Dermoscopic-Histopathologic Correlation.
    Am J Dermatopathol. 2023;45:142-144.
    PubMed         Abstract available

  4. SALAH HT, Czelusta AJ, Sanchez RL
    Reactive Eccrine Syringofibroadenoma (ESFA) in Association With a Merkel Cell Carcinoma Excision Scar.
    Am J Dermatopathol. 2023;45:137-141.
    PubMed         Abstract available

  5. FERNANDEZ-FLORES A, Garcia-Paino L, Peron AS, Cassarino D, et al
    Ungual Keratoacanthoma With Features of Regression.
    Am J Dermatopathol. 2023;45:113-116.
    PubMed         Abstract available

  6. DE WET J, Plessis PJD, Schneider JW
    Staged Excision of Lentigo Maligna of the Head and Neck: Assessing Surgical Excision Margins With Melan A, SOX10, and PRAME Immunohistochemistry.
    Am J Dermatopathol. 2023;45:107-112.
    PubMed         Abstract available

  7. MULLER CSL, Bourg C, Schweitzer LF, Friesenhahn-Ochs B, et al
    Injection Site Reaction to Various Insulins as Type III Allergy With Urticarial Vasculitis in a Patient With Type I Diabetes Mellitus.
    Am J Dermatopathol. 2023;45:86-89.
    PubMed         Abstract available

    BMC Cancer

  8. ZHOU S, Lv H, Li A, Li M, et al
    A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio >/= 2.0 and an average HER2 copy number < 4.0 per cell in China.
    BMC Cancer. 2023;23:84.
    PubMed         Abstract available

  9. LIEDE A, Sebby W, Miriyala AKR, Potluri R, et al
    Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States.
    BMC Cancer. 2023;23:78.
    PubMed         Abstract available

    Br J Dermatol

  10. A new genetic cause for woolly hair and skin fragility.
    Br J Dermatol. 2023;188:e8.

  11. Clinical trial of Oleogel-S10 (birch bark extract gel) in epidermolysis bullosa.
    Br J Dermatol. 2023;188:e4.

  12. Lived experiences of patients with hidradenitis suppurativa-related pain.
    Br J Dermatol. 2023;188:e6.

  13. Providing new insights into the causes of large-to-giant congenital melanocytic naevi.
    Br J Dermatol. 2023;188:e7.

  14. KOGAME T, Yonekura S, Lovato P, Hirata M, et al
    Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis.
    Br J Dermatol. 2023;188:146-148.

  15. STARK MS
    Deficiencies in mismatch DNA repair: providing the soil for large-to-giant congenital melanocytic naevus development.
    Br J Dermatol. 2023;188:5.

  16. BERTOLD C, Martel P, Passeron T, Bahadoran P, et al
    Pigmented demodicosis presenting as lentigo maligna diagnosed by reflectance confocal microscopy.
    Br J Dermatol. 2023;188:149-150.

  17. WANG H, Lin Z
    Identification of the underlying gene for Flegel disease: another 'two-hit' genodermatosis?
    Br J Dermatol. 2023;188:7-8.

    EASE-y does it: Oleogel-S10 for epidermolysis bullosa wounds.
    Br J Dermatol. 2023;188:10-11.

  19. OKUN MM
    The promise of personalized medicine for hidradenitis suppurativa.
    Br J Dermatol. 2023;188:3.

  20. JACKSON A, Moss C, Chandler KE, Balboa PL, et al
    Biallelic TUFT1 variants cause woolly hair, superficial skin fragility and desmosomal defects.
    Br J Dermatol. 2023;188:75-83.
    PubMed         Abstract available

  21. ORENSTEIN LAV, Salame N, Siira MR, Urbanski M, et al
    Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
    Br J Dermatol. 2023;188:41-51.
    PubMed         Abstract available

  22. MOSS C, Roked F, Davis PJ, Khan M, et al
    Birth incidence and outcome of harlequin ichthyosis and collodion membrane in the UK and Ireland: a national 2-year prospective surveillance study.
    Br J Dermatol. 2023;188:139-140.

  23. KEARNEY N, Kirby B
    The devastating impact of hidradenitis suppurativa on employment.
    Br J Dermatol. 2023;188:9-10.

  24. THACI D, Vender R, de Rie MA, Conrad C, et al
    Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
    Br J Dermatol. 2023;188:22-31.
    PubMed         Abstract available

  25. MIRALI S, Yeung J
    Does bimekizumab stand the test of time for psoriasis?
    Br J Dermatol. 2023;188:5-6.

  26. SCHNEIDER-BURRUS S, Kalus S, Fritz B, Wolk K, et al
    The impact of hidradenitis suppurativa on professional life.
    Br J Dermatol. 2023;188:122-130.
    PubMed         Abstract available

  27. ZHANG J, Schuttelaar MLA
    Water and adult eczema: the hard truth?
    Br J Dermatol. 2023;188:e1.

  28. AUBERT H, Arlegui H, De Rycke Y, Bachelez H, et al
    Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry.
    Br J Dermatol. 2023;188:150-152.

  29. WEI B, Gu J, Gao B, Bao Y, et al
    Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis.
    Br J Dermatol. 2023;188:64-74.
    PubMed         Abstract available

  30. YUMICEBA V, Spielmann M
    When too much is too much: noncoding duplications in skin disorders.
    Br J Dermatol. 2023;188:e2-e3.

  31. JAGLE S, Hsu HH, Juratli HA, Zimmer AD, et al
    Pathogenic variants in the SPTLC1 gene cause hyperkeratosis lenticularis perstans.
    Br J Dermatol. 2023;188:94-99.
    PubMed         Abstract available

  32. BROWN AC, Earp EM, Veitch D, Wernham A, et al
    The top 10 research priorities for skin cancer surgery in the UK: results of a James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2023;188:141-142.

  33. VINCENT R, Ormerod E, Gollins CE, Rai N, et al
    Semi-virtual patch testing: the future?
    Br J Dermatol. 2023;188:137-139.

  34. OYMANNS M, Daum-Marzian M, Bellm A, Elsayad K, et al
    Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma.
    Br J Dermatol. 2023;188:145-146.

  35. GABES M, Donhauser T, Kann G, Masur C, et al
    Burden of disease: assessing quality-of-life impacts in hyperhidrosis.
    Br J Dermatol. 2023;188:143-145.

  36. SHIONOYA A, Yoto Y, Hida T, Ishikawa A, et al
    Bacillus Calmette-Guerin-induced lupus vulgaris in a patient with Mendelian susceptibility to mycobacterial disease caused by a novel STAT1 variation.
    Br J Dermatol. 2023;188:142-143.

  37. HAMBLY R, Gatault S, Smith CM, Iglesias-Martinez LF, et al
    B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab.
    Br J Dermatol. 2023;188:52-63.
    PubMed         Abstract available

  38. ZHOU L, Shao L, Gao S, Cui C, et al
    Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy.
    Br J Dermatol. 2023;188:112-121.
    PubMed         Abstract available

  39. CLARK A, Murphy MJ, King B, Cohen JM, et al
    Patient perspectives on the lived experience of granuloma annulare.
    Br J Dermatol. 2023;188:134-136.

  40. KRAKOWSKI I, Habel H, Nielsen K, Ingvar C, et al
    Association of metformin use and survival in patients with cutaneous melanoma and diabetes.
    Br J Dermatol. 2023;188:32-40.
    PubMed         Abstract available

  41. VAN EGMOND S, de Vere Hunt I, Cai ZR, Rizk N, et al
    The perspectives of 606 US dermatologists on active surveillance for low-risk basal cell carcinoma.
    Br J Dermatol. 2023;188:136-137.

  42. KERN JS, Sprecher E, Fernandez MF, Schauer F, et al
    Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
    Br J Dermatol. 2023;188:12-21.
    PubMed         Abstract available

  43. THORLACIUS L, Alam M
    A milestone reached for lichen sclerosus trial outcome standardisation.
    Br J Dermatol. 2023 Jan 27:ljad025. doi: 10.1093.

  44. MCSWEENEY SM, Bintcliffe K, Fassihi H, Sarkany R, et al
    Local cutaneous refractoriness to sun exposure following omalizumab injections in solar urticaria.
    Br J Dermatol. 2023 Jan 27:ljad012. doi: 10.1093.

  45. KVIST-HANSEN A, Perez-Alos L, Al-Sofi RF, Heftdal LD, et al
    Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.
    Br J Dermatol. 2023 Jan 27:ljad023. doi: 10.1093.
    PubMed         Abstract available

  46. SIMPSON RC, Kirtschig G, Selk A, von Seitzberg S, et al
    Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
    Br J Dermatol. 2023 Jan 26:ljac145. doi: 10.1093.
    PubMed         Abstract available

    Safety of tralokinumab in atopic dermatitis.
    Br J Dermatol. 2023 Jan 26:ljad007. doi: 10.1093.

  48. GROLLEAU C, Le Cleach L, Shourick J, Sbidian E, et al
    Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs.
    Br J Dermatol. 2023 Jan 26:ljac142. doi: 10.1093.

  49. PLATAIS C, Lalagianni N, Momen S, Ormond M, et al
    Efficacy of hydroxychloroquine in oral lichen planus: a retrospective review.
    Br J Dermatol. 2022 Dec 3:ljac113. doi: 10.1093.

  50. Patients with melanoma and diabetes benefit from metformin treatment.
    Br J Dermatol. 2023;188:e5.

  51. FISCHER J, Alter S
    Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing.
    Br J Dermatol. 2023;188:8-9.

  52. SO C, McCarthy D, Watts CG, Kearney C, et al
    Diagnostic biopsies of suspected skin cancer in general practice from 2010 to 2017 in Victoria, Australia.
    Br J Dermatol. 2022 Dec 22:ljac111. doi: 10.1093.

  53. VEGAS LP, Claudepierre P
    Trajectories of comorbidities in patients with psoriasis: a question to be answered.
    Br J Dermatol. 2022 Dec 21:ljac126. doi: 10.1093.

  54. SCHELL SL, Cong Z, Sennett ML, Gettle SL, et al
    Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
    Br J Dermatol. 2022 Nov 17:ljac096. doi: 10.1093.
    PubMed         Abstract available

    Cancer Lett

  55. WANG L, Mi D, Hu J, Liu W, et al
    A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.
    Cancer Lett. 2023;555:216049.
    PubMed         Abstract available

  56. LEE Y, Graham P, Li Y
    Extracellular vesicles as a novel approach for breast cancer therapeutics.
    Cancer Lett. 2022 Dec 12:216036. doi: 10.1016/j.canlet.2022.216036.
    PubMed         Abstract available

    Cancer Res

  57. SUN Y, Li X, Yin C, Zhang J, et al
    AMPK phosphorylates ZDHHC13 to increase MC1R activity and suppress melanomagenesis.
    Cancer Res. 2023 Jan 26:CAN-22-2595. doi: 10.1158/0008-5472.CAN-22-2595.
    PubMed         Abstract available

    Clin Exp Dermatol

  58. RUGGIERO A, Marasca C, Fabbrocini G, Mascolo M, et al
    A unilateral slow-growing yellow nodule of the glans penis.
    Clin Exp Dermatol. 2023;48:48-50.

  59. GAMBICHLER T, Susok L, Doerler M, Dickel H, et al
    Lofgren syndrome associated with scleroedema adultorum of Buschke.
    Clin Exp Dermatol. 2023;48:39-40.

  60. ZHENG B, Chen J, Qian Q, Lin X, et al
    Iso-Kikuchi syndrome: report of a Chinese case.
    Clin Exp Dermatol. 2023;48:38-39.

  61. MOLEDINA Z, McPhee M, Ravenscroft JC, Healy E, et al
    How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.
    Clin Exp Dermatol. 2023;48:20-23.
    PubMed         Abstract available

  62. POTESTIO L, Genco L, Noto M, Fabbrocini G, et al
    Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.
    Clin Exp Dermatol. 2023;48:44-45.

  63. JUNEJO MH, Demirel S, Matin R, Proby C, et al
    CorrespondenceShort shock or slow burn? Patient perspectives on treatment of actinic keratoses with 5-fluorouracil 5% cream monotherapy versus 5-fluorouracil plus calcipotriol combination therapy.
    Clin Exp Dermatol. 2023;48:31-32.

  64. WINTER SMK, Ali FM, May KJ, Motley RJ, et al
    An enlarging nodule on the vertex of scalp in an elderly man.
    Clin Exp Dermatol. 2023;48:51-53.

  65. MARTORA F, Battista T, Fabbrocini G, Potestio L, et al
    Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'.
    Clin Exp Dermatol. 2023;48:35-36.

  66. LEAHY M, Griffin L, Harrington R, Laing ME, et al
    Poor availability in Ireland of hats meeting sun-protective standards.
    Clin Exp Dermatol. 2023;48:32-34.

  67. FOLCH H, Jahr C, Giacaman P, Zuniga P, et al
    Hypertrophic genital herpes simplex due to HSV 2 sensitive to maximum dose of oral aciclovir.
    Clin Exp Dermatol. 2023;48:43-44.

  68. SCHLOSSER AR, Shareef M, Olydam J, Nijsten TEC, et al
    Tralokinumab for moderate-to-severe atopic dermatitis patients: first daily practice results.
    Clin Exp Dermatol. 2023 Jan 26:llad038. doi: 10.1093.
    PubMed         Abstract available

  69. HAN J, Baek P, Correa Da Rosa J, Young JN, et al
    The pursuit of equity in skin cancer prevention: a survey-based investigation of total body skin exam awareness and utilization across Fitzpatrick Skin Type.
    Clin Exp Dermatol. 2023 Jan 26:llad009. doi: 10.1093.

  70. REGUIGUI LS, Purdy KS, Wright G
    Generalized urticated papules and plaques with facial swelling.
    Clin Exp Dermatol. 2023 Jan 24:llad022. doi: 10.1093.

  71. PUNCHIHEWA N, Anthony O, Rodrigues M
    The introduction of skin of colour dermatology into the Australian dermatology training curriculum: trainee perspectives 5 years later.
    Clin Exp Dermatol. 2023 Jan 3:llac125. doi: 10.1093.

    Int J Cancer

  72. HEY J, Halperin C, Hartmann M, Mayer S, et al
    DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors, and prognostic value relevant to triple-negative breast cancer patients.
    Int J Cancer. 2022 Nov 21. doi: 10.1002/ijc.34364.
    PubMed         Abstract available

  73. QIN Z, Li J, Tam B, Sinha S, et al
    Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.
    Int J Cancer. 2023;152:1159-1173.
    PubMed         Abstract available

  74. ALCARAZ LB, Mallavialle A, Mollevi C, Boissiere-Michot F, et al
    SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.
    Int J Cancer. 2022 Nov 8. doi: 10.1002/ijc.34345.
    PubMed         Abstract available

  75. LYNGE E, Vjeborg I, Lillholm M, Nielsen M, et al
    Breast Density and Risk of Breast Cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34316.
    PubMed         Abstract available

  76. HEIKKINEN S, Demers PA, Hansen J, Jakobsen J, et al
    Incidence of cancer among Nordic police officers.
    Int J Cancer. 2023;152:1124-1136.
    PubMed         Abstract available

    Int J Dermatol

  77. SERETIS K, Bounas N, Lampri E, Lykoudis EG, et al
    Is adenoid basal cell carcinoma a low or high risk for recurrence histological subtype? A case-control study.
    Int J Dermatol. 2023 Jan 24. doi: 10.1111/ijd.16592.

  78. AMBUR A, Foss M, Mammino J, Saeed S, et al
    Nasal-type extranodal natural killer/T-cell lymphoma presenting as multiple cutaneous masses.
    Int J Dermatol. 2023 Jan 22. doi: 10.1111/ijd.16591.

  79. TRUONG K, Bhattacharyya A, Smee R, Kim J, et al
    Pralatrexate and total skin electron beam therapy as bridging agents to allogeneic stem cell transplantation in severely treatment-refractory Sezary syndrome.
    Int J Dermatol. 2023 Jan 22. doi: 10.1111/ijd.16587.

    Ulcerated cutaneous lesions in type 1 lepra reaction healing with morpheaform scarring: an unusual presentation.
    Int J Dermatol. 2023 Jan 22. doi: 10.1111/ijd.16586.

    J Cutan Pathol

  81. CHEN KL, Hinshaw MA
    Histopathologic characterization of onychomycosis in nail biopsies: A retrospective case series of 19 patients.
    J Cutan Pathol. 2023;50:103-105.

  82. SHAHRIARI N, Grant-Kels JM, Rabinovitz H, Oliviero M, et al
    Reflectance confocal microscopy of facial neoplasms: Follicular involvement as a clue to diagnosis.
    J Cutan Pathol. 2023;50:178-184.
    PubMed         Abstract available

  83. MCAFEE JL, Scarborough R, Jia XS, Azzato EM, et al
    Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.
    J Cutan Pathol. 2023;50:155-168.
    PubMed         Abstract available

  84. AGRAWAL S, Fritchie KJ, Fernandez AP, Ko JS, et al
    The capillary lobule variant of radiation-associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall.
    J Cutan Pathol. 2023;50:140-146.
    PubMed         Abstract available

  85. VERZI AE, Broggi G, Caltabiano R, Micali G, et al
    Line-field confocal optical coherence tomography of lentigo maligna with horizontal and vertical histopathologic correlations.
    J Cutan Pathol. 2023;50:118-122.
    PubMed         Abstract available

  86. WANG LL, Abbott JJ, Jiang AJ, Hannah C, et al
    Pleomorphic acquired digital fibrokeratoma: A novel clinicopathologic entity.
    J Cutan Pathol. 2023;50:131-133.
    PubMed         Abstract available

  87. THOMAS JL, Tee MW, Harp J, Magro C, et al
    Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis.
    J Cutan Pathol. 2023;50:127-130.
    PubMed         Abstract available

  88. RUSSELL-GOLDMAN E, MacConaill L, Laga AC, Hanna J, et al
    Deep-penetrating-nevus-like melanoma arising in patients with familial adenomatous polyposis syndrome.
    J Cutan Pathol. 2023 Jan 23. doi: 10.1111/cup.14393.
    PubMed         Abstract available

  89. CRISTIAN P, Sorina D, Liliana R, Corneliu LD, et al
    Lymphocyte-predominant lesional inflammatory infiltrates of the skin are associated with mucosal-dominant phenotype in pemphigus.
    J Cutan Pathol. 2023 Jan 21. doi: 10.1111/cup.14395.
    PubMed         Abstract available

    J Dermatol

  90. LIU N, Zhang C, Hua W
    Dietary inflammatory potential and psoriasis: A cross-sectional study.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16731.
    PubMed         Abstract available

  91. DE DECKER I, Loge T, Hoeksema H, Speeckaert MM, et al
    Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16732.
    PubMed         Abstract available

  92. YOSHIZAKI A, Fujii K, Kanekura T
    Neutrophilic sebaceous adenitis treated successfully with diaminodiphenyl sulfone.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16735.

  93. OHATA C, Anezaki H, Kaneko S, Okazaki F, et al
    Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.
    J Dermatol. 2023 Jan 24. doi: 10.1111/1346-8138.16733.
    PubMed         Abstract available

  94. UEDA M, Kogame T, Egawa G, Kambe N, et al
    A case of Kimura disease with atopic dermatitis successfully treated with baricitinib.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16724.

  95. YUSHARYAHYA SN, Japranata VV, Jonlean R, Legiawati L, et al
    Cutaneous manifestations in elderly patients with confirmed coronavirus disease 2019 and the disease outcomes: A systematic review.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16722.
    PubMed         Abstract available

    J Invest Dermatol

  96. COULOMBE PA, Orosco A
    Inhibiting EGFR Signaling Holds Promise for Treating Palmoplantar Keratodermas.
    J Invest Dermatol. 2023;143:185-188.

  97. SAPAO P, Roberson EDO, Shi B, Assassi S, et al
    Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis.
    J Invest Dermatol. 2023;143:284-293.
    PubMed         Abstract available

  98. MEYER JM, Vavrova K, Radner FPW, Schneider H, et al
    ALOX12B and PNPLA1 Have Distinct Roles in Epidermal Lipid Lamellar Organization.
    J Invest Dermatol. 2023;143:332-335.

  99. BASSET J, Marchal L, Hovnanian A
    EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.
    J Invest Dermatol. 2023;143:294-304.
    PubMed         Abstract available

  100. MACCHIARELLA G, Cornacchione V, Cojean C, Riker J, et al
    Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa.
    J Invest Dermatol. 2023;143:273-283.
    PubMed         Abstract available

  101. HOLM NIELSEN S, Groen SS, Yao Y, Jorgensen AR, et al
    Biomarkers of Tissue Turnover and Systemic Inflammation Are Associated with Disease Severity and Activity in Patients with Hidradenitis Suppurativa.
    J Invest Dermatol. 2023;143:328-331.

  102. HUDEMANN C, Exner Y, Pollmann R, Schneider K, et al
    IgG against the Membrane-Proximal Portion of the Desmoglein 3 Ectodomain Induces Loss of Keratinocyte Adhesion, a Hallmark in Pemphigus Vulgaris.
    J Invest Dermatol. 2023;143:254-263.
    PubMed         Abstract available

  103. RASSEK K, Izykowska K, Zurawek M, Nowicka K, et al
    TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sezary Syndrome from Mycosis Fungoides and Benign Erythroderma.
    J Invest Dermatol. 2023;143:344-347.

  104. FANG H, Xue K, Cao T, Li Q, et al
    CXCL12/CXCR4 Axis Drives the Chemotaxis and Differentiation of B Cells in Bullous Pemphigoid.
    J Invest Dermatol. 2023;143:197-208.
    PubMed         Abstract available

  105. GUICHENEY M, Ducharme O, Caumont C, Gerard E, et al
    Assessment of liquid biopsy in primary cutaneous diffuse large B-Cell lymphoma- leg type.
    J Invest Dermatol. 2023 Jan 21:S0022-202X(23)00020.

    Plast Reconstr Surg

  106. SELBER JC
    Reply: Comparing Outcomes of Robotically Assisted Latissimus Dorsi Harvest to the Traditional Open Approach in Breast Reconstruction.
    Plast Reconstr Surg. 2023;151:344e.

  107. ALBANESE R, Zingaretti N, Caputo GG, Rampino Cordaro E, et al
    Comparing Outcomes of Robotically Assisted Latissimus Dorsi Harvest to the Traditional Open Approach in Breast Reconstruction.
    Plast Reconstr Surg. 2023;151:343e-344e.

  108. LEVY AS, Murphy AI, Ishtihar S, Peysakhovich A, et al
    Lymphatic Microsurgical Preventive Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up.
    Plast Reconstr Surg. 2023;151:413-420.
    PubMed         Abstract available

  109. JEON HB, Jung JH, Im SH, Kim YB, et al
    Association between Immediate Breast Reconstruction and the Development of Breast Cancer-Related Lymphedema.
    Plast Reconstr Surg. 2023;151:214e-222e.
    PubMed         Abstract available

  110. MAYO F
    Breast Surgery with Smooth Anatomical Implants with Fixation System: A Review of the World's Largest Series of Cases.
    Plast Reconstr Surg. 2023;151:207e-213e.
    PubMed         Abstract available

  111. JENSEN JA, Giuliano AE
    Discussion: Revascularization of the Nipple-Areola Complex following Nipple-Sparing Mastectomy.
    Plast Reconstr Surg. 2023;151:263-264.

  112. RANCATI AO, Nahabedian MY, Angrigiani C, Irigo M, et al
    Revascularization of the Nipple-Areola Complex following Nipple-Sparing Mastectomy.
    Plast Reconstr Surg. 2023;151:254-262.
    PubMed         Abstract available

  113. SHAMSUNDER MG, Sheckter CC, Sheinin A, Rubin D, et al
    Impact of High-Deductible Health Plans on Breast Reconstruction: Considerations for Financial Toxicity.
    Plast Reconstr Surg. 2023;151:245-253.
    PubMed         Abstract available

  114. PENG Y, Lu J, Lu S, Zou J, et al
    Paradoxical Changes of Cutaneous Microcirculation and Sympathetic Fibers of Rat Hind Limbs after Sciatic Nerve Compression.
    Plast Reconstr Surg. 2023;151:245-254.
    PubMed         Abstract available

    PLoS Genet

  115. WASHINGTON-HUGHES CL, Roy S, Seneviratne HK, Karuppagounder SS, et al
    Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.
    PLoS Genet. 2023;19:e1010558.
    PubMed         Abstract available

    PLoS One

  116. YANG Q, Zhang C, Liu X, Zhang L, et al
    The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model.
    PLoS One. 2023;18:e0278306.
    PubMed         Abstract available

  117. HE Y, Chen S, Gao X, Fu L, et al
    Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.
    PLoS One. 2023;18:e0280456.
    PubMed         Abstract available

  118. WESTHOFF CC, Muller SK, Jank P, Kalder M, et al
    Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma.
    PLoS One. 2023;18:e0280936.
    PubMed         Abstract available

  119. YAN B, Shi R, Lu YY, Fang DD, et al
    Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer.
    PLoS One. 2023;18:e0279752.
    PubMed         Abstract available

  120. CHUAMANOCHAN M, Nochaiwong S
    Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study.
    PLoS One. 2023;18:e0279566.
    PubMed         Abstract available

  121. MARUF S, Sagar SK, Rashid MMU, Nath P, et al
    Revisiting the diagnosis and treatment of Para Kala-azar Dermal Leishmaniasis in the endemic foci of Bangladesh.
    PLoS One. 2023;18:e0280747.
    PubMed         Abstract available

  122. HU G, Ding Q, Zhong K, Wang S, et al
    Low pretreatment prognostic nutritional index predicts poor survival in breast cancer patients: A meta-analysis.
    PLoS One. 2023;18:e0280669.
    PubMed         Abstract available

  123. SIRITHANAPHOL W, Mahakkanukrauh A, Nanagara R, Foocharoen C, et al
    Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors.
    PLoS One. 2023;18:e0279087.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  124. ITAH Z, Chaudhry S, Raju Ponny S, Aydemir O, et al
    HER2-driven breast cancer suppression by the JNK signaling pathway.
    Proc Natl Acad Sci U S A. 2023;120:e2218373120.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.